Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Neuropore Therapies
AddedFeb 16, 2024
UpdatedJun 18, 2026
Neuropore Therapies

Neuropore Therapies

Pre-Seed

San Diego-based Neuropore Therapies develops disease-modifying treatments for neurodegenerative disorders.

HQ
San Diego, CA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Neuropore Therapies, founded in San Diego, CA, is dedicated to discovering and developing disease-modifying treatments for neurodegenerative disorders such as Parkinson’s and Alzheimer’s diseases. Their mission is to halt the progression of these diseases by targeting their underlying causes, specifically the pathological accumulation of misfolded and aggregated neurotoxic proteins. Neuropore's therapeutic candidates are designed to address these fundamental issues, with a focus on early-stage interventions.

Notable affiliations include a grant from The Michael J. Fox Foundation for Parkinson’s Research, which supports the development of Neuropore's TLR2 program. Key achievements include ongoing clinical trials, such as UCB0599 for early-stage Parkinson’s disease. The company has made significant strides in the field of neurodegenerative research, contributing valuable insights and potential treatments that aim to improve patient outcomes and quality of life.

Neuropore Therapies - Similar Companies

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Orphan Star Therapeutics logo

Orphan Star Therapeutics

Mojave Pharma logo

Mojave Pharma

Neurolink logo

Neurolink

Aspen Neuroscience logo

Aspen Neuroscience

Intellect Neurosciences logo

Intellect Neurosciences

VersaPeutics logo

VersaPeutics

Neuro42 logo

Neuro42

Neurona Therapeutics logo

Neurona Therapeutics

Neurelis logo

Neurelis

neurelis.com

Neurocarrus logo

Neurocarrus

neurocarrus.com

Neuraptive Therapeutics logo

Neuraptive Therapeutics

neuraptive.com

NeuroGenetic Pharmaceuticals logo

NeuroGenetic Pharmaceuticals

Embera Neurotherapeutics logo

Embera Neurotherapeutics

emberaneuro.com

Neurodon logo

Neurodon

neurodon.net

Neuropore Therapies - Quick Facts

Who are Neuropore Therapies' competitors?

Companies similar to Neuropore Therapies include NeuroTherapeutics Pharma, Orphan Star Therapeutics, Mojave Pharma and Neurolink.

When was Neuropore Therapies founded?

Neuropore Therapies was founded in 2008.

Where is Neuropore Therapies' headquarters located?

Neuropore Therapies' headquarters is located in San Diego, CA, US.

When was Neuropore Therapies' last funding round?

Neuropore Therapies' most recent funding round was for $500k (USD) in February 2020.

How much has Neuropore Therapies raised to-date?

As of Feb 17, 2020, Neuropore Therapies has raised a total of $500k (USD).

How many employees does Neuropore Therapies have?

Neuropore Therapies has 13 employees as of Feb 4, 2024.

Neuropore Therapies - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
  • Therapeutics
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 4649Wholesale of other household goods
  • 7210Research and experimental development on natural sciences and engineering
Show 20 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 424000Merchant Wholesalers, Nondurable Goods
  • 424200Drugs and Druggists' Sundries Merchant Wholesalers
  • 424210Drugs and Druggists' Sundries Merchant Wholesalers
  • 420000Wholesale Trade
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 5100Wholesale trade--nondurable goods
  • 5120Drugs, Drug Proprietaries, And Druggists' Sundries
  • 5122Drugs, Drug Proprietaries, and Druggists' Sundries
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified